Literature DB >> 15593392

Immunologic changes to autologous transfusion after operational trauma in malignant tumor patients: neopterin and interleukin-2.

Min Yan1, Gang Chen, Ling-ling Fang, Zi-ming Liu, Xiu-lai Zhang.   

Abstract

OBJECTIVE: To estimate the impact of autologous transfusion on the status of perioperative immune activation in malignant tumor patients. The Serum Neopterin and Interleukin-2 (IL-2) were measured.
METHODS: Sixty patients undergoing elective radical resection for malignant stomach tumor were enrolled in the prospective study and assigned to the following groups: (1) Group A received autologous transfusion. (2) Group H received allogeneic transfusion. The perioperative course (Before induction of anesthesia, after operation and 5 d after operation) of Neopterin and IL-2 was compared.
RESULTS: In group A, Serum Neopterin was significantly lower than baseline after operation and IL-2 had no significant changes. In group H, both Serum Neopterin and IL-2 were significantly lower than baseline after operation and 5 d after operation. Compared with group A, Serum Neopterin was significantly lower than baseline after operation and 5 d after operation and IL-2 was significantly lower than baseline 5 d after operation.
CONCLUSION: Autologous transfusion decreased the perioperative immune suppression in malignant stomach tumor patients.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15593392      PMCID: PMC1390759          DOI: 10.1631/jzus.2005.B0049

Source DB:  PubMed          Journal:  J Zhejiang Univ Sci B        ISSN: 1673-1581            Impact factor:   3.066


  10 in total

Review 1.  Neopterin as marker for activation of cellular immunity: immunologic basis and clinical application.

Authors:  H Wachter; D Fuchs; A Hausen; G Reibnegger; E R Werner
Journal:  Adv Clin Chem       Date:  1989       Impact factor: 5.394

2.  Monocyte function before and after surgical trauma.

Authors:  W Haupt; J Riese; C Mehler; K Weber; M Zowe; W Hohenberger
Journal:  Dig Surg       Date:  1998       Impact factor: 2.588

Review 3.  Interleukin-2: its rationale and role in the treatment of patients with cancer.

Authors:  J T Rubin
Journal:  Cancer Treat Res       Date:  1995

Review 4.  Blood transfusion-induced immunomodulation.

Authors:  D F Landers; G E Hill; K C Wong; I J Fox
Journal:  Anesth Analg       Date:  1996-01       Impact factor: 5.108

5.  Cytokine generation in whole blood, leukocyte-depleted and temporarily warmed red blood cell concentrates.

Authors:  V Weisbach; C Wanke; J Zingsem; R Zimmermann; R Eckstein
Journal:  Vox Sang       Date:  1999       Impact factor: 2.144

6.  Influence of autologous blood transfusion on natural killer and lymphokine-activated killer cell activities in cancer surgery.

Authors:  M M Heiss; K Fasol-Merten; H Allgayer; M A Ströhlein; A Tarabichi; S Wallner; H I Eissner; K W Jauch; F W Schildberg
Journal:  Vox Sang       Date:  1997       Impact factor: 2.144

7.  Neopterin as a marker for cell-mediated immunity in patients with pulmonary tuberculosis.

Authors:  C Immanuel; R Swamy; M Kannapiran; S Vijayalakshmi; V Sundaram; K Jagannath; C N Paramasivan
Journal:  Int J Tuberc Lung Dis       Date:  1997-04       Impact factor: 2.373

8.  Neopterin, soluble IL-2 receptor and IL-6 secretion during IL-2 cancer immunotherapy: prognostic significance in relation to IL-12 variations.

Authors:  P Lissoni; S Barni; G Di Felice; F Majorca; L Fumagalli
Journal:  Int J Biol Markers       Date:  1997 Jul-Sep       Impact factor: 3.248

9.  PGE2 inhibits IL-2 and IL-4-dependent proliferation of CTLL-2 and HT2 cells.

Authors:  T Gurlo; W W Huang; H von Grafenstein
Journal:  Cytokine       Date:  1998-04       Impact factor: 3.861

Review 10.  Cytokine signaling/transcription factor cross-talk in T cell activation and Th1-Th2 differentiation.

Authors:  Ana C Liberman; Damian Refojo; Eduardo Arzt
Journal:  Arch Immunol Ther Exp (Warsz)       Date:  2003       Impact factor: 4.291

  10 in total
  3 in total

1.  Dynamic changes in clot formation determined using thromboelastometry after reinfusion of unwashed anticoagulated cell-salvaged whole blood in total hip arthroplasty.

Authors:  Bernd Froessler; Ingo Weber; Nicolette A Hodyl; Khaschayar Saadat-Gilani
Journal:  Blood Transfus       Date:  2015-06-12       Impact factor: 3.443

2.  Post-traumatic immunosuppression is reversed by anti-coagulated salvaged blood transfusion: deductions from studying immune status after knee arthroplasty.

Authors:  N Islam; M Whitehouse; S Mehendale; M Hall; J Tierney; E O'Connell; A Blom; G Bannister; J Hinde; R Ceredig; B A Bradley
Journal:  Clin Exp Immunol       Date:  2014-08       Impact factor: 4.330

3.  Effect of perioperative autologous versus allogeneic blood transfusion on the immune system in gastric cancer patients.

Authors:  Gang Chen; Feng-jiang Zhang; Ming Gong; Min Yan
Journal:  J Zhejiang Univ Sci B       Date:  2007-08       Impact factor: 3.066

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.